RESULTS: Overall, 540 (25%), 1134 (54%) and 460 (21%) had low, intermediate and high-risk disease according to the D'Amico classication. The 3-year overall BCR-free survival rate was 84%. No signicant differences were observed in the 3-year BCR-free survival between low-and intermediate-risk groups based on the D'Amico classication (92 vs. 87%; P[0.1). The new MVA-based nomogram predicting BCR depicted optimal discrimination at internal validation (AUC 77%), which was higher than the accuracy of the D'Amico risk groups and the CAPRA score (AUC 71% vs. 66%, respectively). Four new risk categories were identied based on the predictors included in the MVA-based nomogram (Figure 1).CONCLUSIONS: We developed a novel preoperative risk tool integrating clinical and radiological parameters to predict early BCR. Our model exhibited higher accuracy compared to available tools in the prediction of early BCR. This stratication might assist physicians in preoperative counselling and treatment selection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.